20 results for author:"Lasa A." in Literature citations
Results Customize
› Repeat search in UniProtKB (23)
| Vibrio toranzoniae sp. nov., a new member of the Splendidus clade in the genus Vibrio. Lasa A., Dieguez A.L., Romalde J.L. Syst. Appl. Microbiol. 36:96-100(2013) · UniProtKB (20) |
| Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. Maxwell C.A., Benitez J., Gomez-Baldo L., Osorio A., Bonifaci N., Fernandez-Ramires R., Costes S.V., Guino E., Chen H., Evans G.J. et al. PLoS Biol. 9:e1001199-e1001199(2011) · Mapped (6) |
| Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer. Blanco A., de la Hoya M., Balmana J., Ramon y Cajal T., Teule A., Miramar M.D., Esteban E., Infante M., Benitez J., Torres A. et al. Breast Cancer Res. Treat. 132:307-315(2012) · Mapped (2) |
| Resveratrol regulates lipolysis via adipose triglyceride lipase. Lasa A., Schweiger M., Kotzbeck P., Churruca I., Simon E., Zechner R., Portillo M.P. J. Nutr. Biochem. 23:379-384(2012) · Mapped (12) |
| Evidence for a link between TNFRSF11A and risk of breast cancer. Bonifaci N., Palafox M., Pellegrini P., Osorio A., Benitez J., Peterlongo P., Manoukian S., Peissel B., Zaffaroni D., Roversi G. et al. Breast Cancer Res. Treat. 129:947-954(2011) · Mapped (6) |
| Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. Osorio A., Milne R.L., Alonso R., Pita G., Peterlongo P., Teule A., Nathanson K.L., Domchek S.M., Rebbeck T., Lasa A. et al. Br. J. Cancer 104:1356-1361(2011) · Mapped (23) |
| Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Antoniou A.C., Beesley J., McGuffog L., Sinilnikova O.M., Healey S., Neuhausen S.L., Ding Y.C., Rebbeck T.R., Weitzel J.N., Lynch H.T. et al. Cancer Res. 70:9742-9754(2010) · Mapped (18) |
| Two founder BRCA2 mutations predispose to breast cancer in young women. Infante M., Duran M., Lasa A., Acedo A., de la Hoya M., Esteban-Cardenosa E., Sanz D.J., Perez-Cabornero L., Lastra E., Miner C. et al. Breast Cancer Res. Treat. 122:567-571(2010) · Mapped (18) |
| Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer Hum. Mol. Genet. 18:4442-4456(2009) · Mapped (25) |
| Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Milne R.L., Osorio A., Ramon y Cajal T., Baiget M., Lasa A., Diaz-Rubio E., de la Hoya M., Caldes T., Teule A., Lazaro C. et al. Breast Cancer Res. Treat. 119:221-232(2010) · Mapped (18) |
| K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML). Carnicer M.J., Lasa A., Buschbeck M., Serrano E., Carricondo M., Brunet S., Aventin A., Sierra J., Di Croce L., Nomdedeu J.F. Ann. Hematol. 87:819-827(2008) · Mapped (2) |
| High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias. Lasa A., Serrano E., Carricondo M., Carnicer M.J., Brunet S., Badell I., Sierra J., Aventin A., Nomdedeu J.F. Ann. Hematol. 87:205-211(2008) · Mapped (7) |
| Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia. Munoz L., Lasa A., Carricondo M.T., Hernandez C., Ubeda J., Nomdedeu J.F. Cytometry B Clin Cytom 72:96-102(2007) · Mapped (3) |
| Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population. Vilchez J.J., Gallano P., Gallardo E., Lasa A., Rojas-Garcia R., Freixas A., De Luna N., Calafell F., Sevilla T., Mayordomo F. et al. Arch. Neurol. 62:1256-1259(2005) · Mapped (6) |
| MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias. Lasa A., Carnicer M.J., Aventin A., Estivill C., Brunet S., Sierra J., Nomdedeu J.F. Leukemia 18:1231-1237(2004) · Mapped (9) |
| FLT3 mutations are associated with other molecular lesions in AML. Carnicer M.J., Nomdedeu J.F., Lasa A., Estivill C., Brunet S., Aventin A., Sierra J. Leuk. Res. 28:19-23(2004) · Mapped (2) |
| Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia. Bellido M., Aventin A., Lasa A., Estivill C., Carnicer M.J., Pons C., Matias-Guiu X., Bordes R., Baiget M., Sierra J. et al. Haematologica 88:994-1001(2003) · Mapped (1) |
| Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Illa I., Serrano-Munuera C., Gallardo E., Lasa A., Rojas-Garcia R., Palmer J., Gallano P., Baiget M., Matsuda C., Brown R.H. Ann. Neurol. 49:130-134(2001) · UniProtKB (1) |
| Calpainopathy -- a survey of mutations and polymorphisms. Richard I., Roudaut C., Saenz A., Pogue R., Grimbergen J.E.M.A., Anderson L.V.B., Beley C., Cobo A.-M., de Diego C., Eymard B. et al. Am. J. Hum. Genet. 64:1524-1540(1999) · UniProtKB (1) |
| Two new variants of RAG-1 protein predicted by SSCP. Nomdedeu J.F., Lasa A., Seminago R., Rubiol E., Baiget M., Soler J. Hum. Mutat. 8:191-192(1996) · UniProtKB (1) |